3-(Bicyclo[1.1.1]pentan-1-yl)azetidine 2,2,2-trifluoroacetate

Catalog No.: 
ACKWOZ216
CAS No.: 
2377030-96-9
Molecular Formula: 
C10H14F3NO2
Molecular Weight: 
237.22
3-(Bicyclo[1.1.1]pentan-1-yl)azetidine 2,2,2-trifluoroacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$759.00InquiryInquiry
100mg98%$949.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Bicyclo[1.1.1]pentan-1-yl)azetidine 2,2,2-trifluoroacetate
IUPAC Name3-(bicyclo[1.1.1]pentan-1-yl)azetidine 2,2,2-trifluoroacetate
MDL No.MFCD32199825
Molecular FormulaC10H14F3NO2
Molecular Weight237.22
SMILESO=C(O)C(F)(F)F.C1(C2(C3)CC3C2)CNC1
InChI KeyUIDOYWZDLIJZJC-UHFFFAOYSA-N
SynonymAzetidine, 3-bicyclo[1.1.1]pent-1-yl-, 2,2,2-trifluoroacetate (1:1);3-(Bicyclo[1.1.1]pentan-1-yl)azetidine Trifluoroacetate;3-(Bicyclo[1.1.1]pentan-1-yl)azetidine 2,2,2-trifluoroacetate
CAS No.2377030-96-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKWOZ216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKWOZ216 route product structure diagram
    ACKWOZ2162377030-96-9
Inquiry

2. ACKWOZ216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKWOZ216 route product structure diagram
    ACKWOZ2162377030-96-9
Inquiry

3. ACKWOZ216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKWOZ216 route product structure diagram
    ACKWOZ2162377030-96-9
Inquiry

Comments (0)